Mechanistic convergence of Astragalus-derived phytochemicals in Alzheimer’s disease: A systematic review

Yashvi Bhatt · 2026

Read Mechanistic convergence of Astragalus-derived phytochemicals in Alzheimer’s disease: A systematic review by Yashvi Bhatt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13471358.txt.

Description

Bhatt reviewed in 2026 whether Astragalus, a plant genus long used in traditional medicine, can protect the brain in Alzheimer's disease. The review gathered lab and early human studies by standard PRISMA rules. Astragalus yields saponins, flavonoids, and polysaccharides, plant chemicals with reported brain effects.

Across studies, these compounds acted on several cell pathways at once, including PI3K/Akt, Nrf2/ARE, MAPK, and NF-κB. Together they cut oxidative stress, calmed brain inflammation, reduced cell death, and improved synapse function. Some studies also found less amyloid harm and less damaging tau change. The author frames the pattern as systems-level: one plant family pressing many connected targets at once. Human proof is still thin, though. The review presents Astragalus as a multi-target candidate that needs rigorous trials, not a proven remedy.

Catalog record

CREATORYashvi Bhatt
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13471358

Browse the full library · About the Tower of Babel